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In addition to their detrimental role in allergic diseases, mast cells (MCs) are well known to
be important cells of the innate immune system. In the last decade, they have been shown
to contribute signiﬁcantly to optimal host defense against numerous pathogens including
parasites, bacteria, and viruses. The contribution of MCs to the immune responses in fun-
gal infections, however, is largely unknown. In this review, we ﬁrst discuss key features of
mast cell responses to pathogens in general and then summarize the current knowledge
on the function of MCs in the defense against fungal pathogens. We especially focus on
the potential and proven mechanisms by which MCs can detect fungal infections and on
possible MC effector mechanisms in protecting from fungal infections.
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INTRODUCTION: MAST CELLS AND INNATE IMMUNITY
Mast cells (MCs) are important effector cells in protective immune
responses against pathogens (Marshall, 2004; Galli et al., 2005).
They are long-lived cells (surviving, in some cases, for years) with
the capacity to respond repeatedly to the same stimulus. They
reside in and migrate to tissues that are commonly exposed to
the external environment, such as the skin, airways, and intestine,
where they can initiate and enhance early responses to envi-
ronmental threats including pathogens. MCs are preferentially
located in the vicinity of blood vessels, nerves, and lymphatic ves-
sels, can regulate vascular permeability and instigate effector cell
recruitment by releasing preformed as well as de novo synthesized
mediators (Moon et al., 2010). MCs have a wide variety of cell
surface receptors that play an important role in the detection of
harmful pathogens. The interactions betweenMCs and pathogens
are essential for the generation of early innate immune responses
(Metz and Maurer, 2007). On appropriate activation,MCs release
a multitude of biologically potent inﬂammatory mediators with
diverse functions, and many of these MC products signiﬁcantly
contribute to innate immune responses (Metz and Maurer, 2009;
Abraham and St John, 2010). MCs are a potential source of early
response cytokines, such as tumor necrosis factor α (TNF-α)
and IL-4, that are decisive in initiating and directing the course
of immune and inﬂammatory responses in the host (Marshall,
2004). MCs make and secrete an abundance of peptidases such
as tryptases and chymases which are important and even critical
for host defense and homeostasis (Trivedi and Caughey, 2010).
Because of their strategic location, the presence of different types
of receptors and the unique property to release potent mediators
according to speciﬁc pathogen, MCs are very important effector
cells in immune responses to infection.
ROLE OF MAST CELLS IN BACTERIAL INFECTION
Mast cells are by now well established to play an important
role in optimal host defense in innate immune responses to
bacterial infections. A number of studies have identiﬁed the
critical importance of MCs in host immune defense against bac-
teria through the release of various substances including TNF-α,
leukotrienes, and proteases (Metz and Maurer, 2007).
In response to bacterial infection, MCs can be activated by
a number of different surface molecules. For example, in the
context of a bacterial infection, MCs can be activated by com-
plement receptors, which can be directly activated by bacte-
ria, i.e., via CD48, the receptor for FimH expressed by many
bacteria (Malaviya et al., 1994, 1999), and G-protein coupled
receptors for peptides such as endothelin-1 or neurotensin-1
which are upregulated during bacterial infection (Maurer et al.,
2004; Galli and Tsai, 2010). Furthermore, recognition of bacte-
rial constituents by MCs is dependent on the presence of pat-
tern recognition receptors (PRRs), such as Toll-like receptors
(TLRs), which are important in innate immune strategy. MCs
express most TLRs, though there are some important species-
speciﬁc differences in the expression and function of TLRs on
MCs. TLR-ligands can directly activate MCs causing release of
MC mediators in distinctive patterns (Supajatura et al., 2002;
McCurdy et al., 2003; Varadaradjalou et al., 2003; Kulka et al.,
2004). TLR2 and TLR4 are particularly important in mediating
MC responses against bacteria. Animalmodels have demonstrated
that TLR2-dependent MC activation contributes to the control of
Mycobacterium tuberculosis infection while TLR2−/− mice display
increased mycobacterial burden, diminished myeloid cell recruit-
ment and pro-inﬂammatory cytokine production accompanied by
defective granuloma formation (Carlos et al., 2009).
Different receptors expressed on MCs play important roles in
the recognition of pathogens and initiate signaling pathways that
result in mediator release. These mediators are crucial for host
defense responses. MC-derived TNF-α is thought to play a sig-
niﬁcant role in recruiting neutrophils to the sites of infection. In
addition, TNF-α has been demonstrated to provide antibacterial
protection in MC-deﬁcient mice (Malaviya et al., 1996). Interest-
ingly, the protective effects of MCs in septic peritonitis can be
enhanced by increasing the number of MCs, even in the absence
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of TNF-α indicating that additional MC-derived products can be
important for optimal host defense (Maurer et al., 1998). Mast
cells can also release their mediators without degranulation, for
example LPS and peptidoglycan do not induce degranulation yet
both enhance expression of promatrix metalloproteinase-9 (pro-
MMP-9) in a dose-dependent manner (Ikeda and Funaba, 2003).
Increased production of IL-6 by MCs in response to TLR2 acti-
vation can play a crucial role in the protection against bacterial
infection (Haidl et al., 2011). Infection of MCs with live Strepto-
cocci causes a TLR2- and cell–cell contact-dependent release of IL-
4, IL-6, IL-12, IL-13, and TNF-α, and chemokines (CCL2/MCP-1,
CCL7/MCP-3, CXCL2/MIP-2, CCL5/RANTES) (Ronnberg et al.,
2010). Most of the in vivo work on MC functions in antibacterial
host defense has been done using models of bacterial infections
in the peritoneum; however, several publications have shown that
the ﬁndings of these studies hold true in other anatomical sites
such as the middle ear (Ebmeyer et al., 2005), the lung (Xu et al.,
2006), and the skin (Siebenhaar et al., 2007).
It is well recognized that MCs have phagocytic capabilities,
more importantly,MCs can also exhibit direct bactericidal activity,
e.g., by releasing cathelicidins (Di Nardo et al., 2003) or proteases
(Orinska et al., 2007). Furthermore, MCs have been shown to
be able to kill bacteria by entrapping them in extracellular struc-
tures termed as mast cell extracellular trap (MCETs) composed of
DNA, histones, tryptase, and cathelicidin antimicrobial peptides
(von Kockritz-Blickwede et al., 2008).
MAST CELL RESPONSES TO VIRAL INFECTIONS
The contribution of MCs to host defense in viral infections is not
much explored, either due to the lack of suitable mouse models
of viral infection or that it has not been tested in MC deﬁcient
mouse models so far. More and more research endeavors are now
focused on elucidating interactions between MCs and viruses.
MCs can be activated by viruses via TLR3 (Marshall, 2004; Orin-
ska et al., 2005). TLR3 activation decreases MC attachment to
ﬁbronectin and vitronectin and abrogates MC attachment depen-
dent potentiation of IgE-mediated responses (Kulka andMetcalfe,
2006). MCs contribute to immune responses to viral infection
by the production of type I IFNs after being exposed to double-
stranded RNA and/or virus via TLR3 (Kulka et al., 2004). On
the other hand, MCs stimulated via TLR3 are potent regulators
of antiviral CD8+ T-cell activities in vitro and in vivo (Orin-
ska et al., 2005). MCs release cytokines, chemokines, and lipid
mediators on activation and/or infection by viruses as a protective
immune response (Wedde-Beer et al., 2002; Dawicki and Mar-
shall, 2007). Major MC mediators such as histamine, proteases,
and leukotrienes are known to profoundly alter the nature of
the innate immune response and its effectiveness in eliminating
infection. Mediator release from MCs after viral infection is well
explored as described in different reviews (Marshall et al., 2003;
Metz and Maurer, 2007).
Indifferent diseasemodels,MCshavebeen shown tohave apro-
tective antiviral role. MCs sensitized with dengue virus immune
sera and upon contact with Sendai virus show degranulation as
well as histamine release (Sugiyama, 1977; Sanchez et al., 1986).
The gp120 envelope protein of HIV can induce IL-4 and IL-13 pro-
ductionbyMCs (Patella et al.,2000) andMC-derived interleukin-1
family cytokines exhibit protective effects against inﬂuenza virus
(Kayamuro et al., 2010). MCs can selectively produce several
mediators including IL-1β, IL-6, CCL3, CCL4, and CCL5 after
FcγRII-mediated dengue virus infection (King et al., 2000, 2002;
Brown et al., 2006). MCs further play an important role in the
clearance of dengue virus by recruitment of natural killer (NK)
and NKT-cells (St John et al., 2011). Antibody-enhanced dengue
virus infection among CBMCs and HMC-1 results in increased
expression of the adhesion molecules ICAM-1 andVCAM-1. This
effect is mediated through TNF-α (Brown et al., 2011). A recent
report indicated the protective role of MCs against vaccinia virus
by triggering its speciﬁc receptor, Sphingosine-1-phosphate recep-
tor 2 (S1PR2), and releasing antimicrobial peptides (Wang et al.,
2012). It has to be noted, that althoughmost of these ﬁndings indi-
cate a possible beneﬁcial role for MCs in viral infection there may
be circumstances in which the role of MCs could be detrimental.
For example, Sundstrom et al. (2007) reported that HIV-infected
human tissueMCsmight comprise a long-lived inducible reservoir
of persistent HIV in infected individuals. MCs co-cultured with
respiratory syncytial virus (RSV)-infected A549 airway epithe-
lial cells show degranulation and increased TNF-α secretion. It
is worth mentioning that the role of MCs in response to RSV has
been associated with the exacerbation or development of asthma
(Shirato and Taguchi, 2009).
CONTRIBUTION OF MAST CELLS IN PARASITIC INFECTION
MCs have long been known to play a role in host defense responses
against parasitic infections (Miller and Jarrett, 1971). MCs are
involved in both innate and adaptive immune responses to par-
asites. Their ability to respond rapidly to infections by releasing
pre-stored inﬂammatory mediators contributes to the ﬁrst line
of response to parasitic pathogens (Galli et al., 2008). MCs can
participate in innate immunity, during local cutaneous infection
with Leishmania parasites. Bone marrow-derived MCs (BMMCs)
in contact with living L. major or L. infantum promastigotes
reportedly release preformedmediators such as β-hexosaminidase
and the preformed pool of TNF-α (Bidri et al., 1997). MCs
can control parasites by various mechanisms, e.g., by recruit-
ment of effector immune cells like neutrophils, regulation of
gut permeability, and expulsion of parasites. MCs are preferen-
tially located in organs targeted by parasites, e.g., the skin and
gut. MCs express receptors for parasites (e.g., TLRs 1, 4, and
9), which allow MCs to react directly to parasitic stimuli. In
the early response, MCs release preformed mediators that are
important for the defense against parasites. MC proteases have
been shown to play a pivotal role in some of these responses
(Metz and Maurer, 2007). In parasite infections, the chymases
mMCP-1 and mMCP-9 have, for example, been shown to con-
tribute to the expulsion of nematodes (King et al., 2000; McDer-
mott et al., 2003; Sasaki et al., 2005). Furthermore, histamine
release from MCs via IgE-independent or IgE-mediated immune
responses, is known to play a major role in parasite transmission
and malaria pathogenesis (Mecheri, 2012) by causing release of
nitric oxide as well as by enhancing vascular permeability (Van
de Voorde and Leusen, 1983). These effects of histamine might
be exploited by Plasmodium parasite to survive in its mammalian
host.
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MCs are preferentially distributed throughout barrier tis-
sues such as the skin and mucosa, including the intraep-
ithelial space of the intestine. For instance, infection by the
nematodes Strongyloides venezuelensis or Trichinella spiralis,
which usually occur in the gut, induce a cytokine-dependent
increase in MC numbers in the intestinal mucosa (Lantz et al.,
1998; McDermott et al., 2003; Sasaki et al., 2005). Prolif-
eration of MCs during gut helminth infection is found to
be dependent on stem cell factor (Newlands et al., 1995)
as well as IgE (Asai et al., 2001). MCs also appear to be
vital for cutaneous immunity during the parasitic skin infec-
tion leishmaniasis, endorsing protective immunity, including T-
cell function, and controlling skin lesion size (Maurer et al.,
2006).
In general, MCs are widely considered to be important late
stage effector cells during Th2 associated immune responses,
which includes host responses against parasitic helminths in
mucosal tissues (Pennock and Grencis, 2006; Hakim-Rad et al.,
2009). For example, resistance to infection is characterized by the
production of IL-4, IL-5, IL-9, parasite-speciﬁc immunoglobu-
lin G1 (IgG1) response, and higher expression of MC markers
(CD117 and FcεRI) as well as Th2 associated cytokines in livers
of Ascaris-infected pigs (Dawson et al., 2009). T. gondii infec-
tion reportedly results in the enhancement of MCs numbers
as well as inﬂux of other effector cells like neutrophils indi-
cating that MCs are intricately involved with the acute phase
of the inﬂammatory response in this experimental model (Fer-
reira et al., 2004). MCs can exert cytotoxicity against T. gondii
infection which is attributed to Leukotriene B4 produced upon
activation (Henderson and Chi, 1998). MCs also contribute to
protective immune responses against Plasmodium berghei in a
mouse model of malaria by releasing TNF-α (Furuta et al.,
2006), and MC-deﬁcient mice show higher parasitemia and
lower TNF-α as compared to wild type mice (Furuta et al.,
2006).
MCs also act at the interface between innate and acquired
immunity during parasitic infection. mMCP-6 was found to be
a critical link between adaptive and innate immunity in the
chronic phase of T. spiralis infection (Shin et al., 2008). MCs
can importantly contribute to the early innate events that deter-
mine the priming of adaptive immunity. Hepworth et al. (2012)
recently described an IgE-independent role for MCs in orches-
trating antiparasite type 2 immune responses involving effects of
IL-25, IL-33, and TSLP.
CHARACTERIZING THE ROLE OF MAST CELLS IN FUNGAL
INFECTION: THE NEED OF THE HOUR
The role of MCs in antifungal defense is an almost unexplored
area of research, and in contrast to infections by bacteria, viruses,
and parasites, very little is known about the relevance of MC
effects in fungal infections (Maurer et al., 2006; Siebenhaar et al.,
2007). This is surprising because fungi, just like other pathogens,
enter the body via MC rich organs (skin, gut, airways) and
because MCs express several receptors and mediators known to
be involved in antifungal responses (Wedemeyer et al., 2000;
Metz and Maurer, 2007). In addition, host defense responses to
fungal pathogens share many characteristic features of MC-driven
immune responses against bacteria and parasites (Metz et al.,
2008; Metz and Maurer, 2009). Fungal infections are affecting an
increasing number of people, current treatment options are not
sufﬁcient, and the mortality of invasive fungal infection remains
unacceptably high. Therefore, it is important to better understand
the contribution ofMCs during fungal infections, as thismay facil-
itate the development of novel and better treatment options for
these diseases.
SITES OF FUNGAL INFECTIONS, HINTS FROM MAST CELL
DISTRIBUTION
FUNGAL INFECTION IN SKIN
Fungal skin infections are amongst the most widespread and
common infections in humans. Cutaneous and superﬁcial fun-
gal infections are known to be caused primarily by dermato-
phytes, yeast and a limited number of ﬁlamentous fungi such as
Aspergillus,Acremonium, Fusarium,Neoscytalidium, and Scopular-
iopsis (Saunte et al., 2012).
As described before in more detail, skin MCs represent one
of the ﬁrst inﬂammatory components to get in contact with
pathogens and they can respond to various pathogens in many
ways. By these mechanisms, MCs could, for example, contribute
to antifungal immune responses by releasing IL-10 directly at the
site of infection. IL-10 has been demonstrated to be important for
controlling infections with several pathogenic fungi in experimen-
tal models (Romani et al., 1994; Tonnetti et al., 1995; Vecchiarelli
et al., 1996; Monari et al., 1997; Fierer et al., 1998). Furthermore,
MCs have also been shown to participate as IL-10 producing cells
in the local immune response against Paracoccidioides brasiliensis
in skin lesions characterized by a Th2 pattern of cytokines (Pagliari
et al., 2006). In general, dermatomycoses are caused by ﬁlamen-
tous fungi such as Trichophyton,Microsporum, or Epidermophyton
species. These fungi, which can cause infection in human and
domestic animals, have a high afﬁnity for keratin, an important
component of hair, skin, and nails. Interestingly, MCs are prefer-
entially localized at the classical sites of cutaneous fungal infection,
e.g., around hair follicles.
Other fungi potentially relevant for the skin are of the Candida
species (all yeasts),of whichCandida albicans is themost common.
In immunocompetent persons, candidiasis is usually a localized
infection of the skin or more often of the mucosal membranes,
including the oral cavity (thrush), the pharynx or esophagus, the
gastrointestinal tract, the urinary bladder, or the genitalia. The role
of MCs in candidiasis is largely unknown, although an older report
indicated thatMCs could be involved in the inﬂammatory process,
and thus possibly in the defense against the fungus by releasing his-
tamine after activation via a glycoprotein from C. albicans (Nosal,
1974).
FUNGAL INFECTION IN LUNGS
Fungi may cause lung diseases through direct infection of pul-
monary tissue, infection of pulmonary air spaces/lung cavities,
or through their ability to trigger an immunological reaction
when fungal materials are inhaled. Fungi are thought to serve
both as immunogenic antigens and as adjuncts to inﬂammation
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through protease activity and are associated with allergic asthma.
Aspergillus fumigatus can be regarded as the most important
airborne-pathogenic fungus, and it causes the disease aspergillosis
due to invasion in the lungs (Agarwal and Gupta, 2011). Fun-
gal lung infections are more likely to be severe in people who
have underlying lung disease and/or compromised immune sys-
tems such as those with HIV/AIDS. Both acute and chronic fungal
infections can causepermanent lungdamage and canbe fatal (Boy-
ton, 2005). Due to their strategic localization in the lung,MCs can
readily interact with invading fungi and may play a protective role
in different fungal disease including aspergillosis. As of now, how-
ever, there are no reports that show that MCs are importantly
involved in lung fungal infections in vivo. Future research has to
be carried out by employing appropriate animal models of fungal
airway and lung infections in MC deﬁcient mouse models.
FUNGAL INFECTION IN THE GASTROINTESTINAL TRACT
The gastrointestinal tract is one of the preferred sites for MCs
to localize, and, in contrast to skin MCs, the number of MCs
can rapidly and markedly expand during the course of an infec-
tion in the gut; this allows for a high degree of interaction
between MCs and gut ﬂora (Mikkelsen, 2010). Candida colo-
nization is associated with several diseases of the gastrointesti-
nal tract, e.g., Crohn’s disease (Rehaume et al., 2010), ulcera-
tive colitis (Zwolinska-Wcislo et al., 2009), and gastric ulcers
(Hirasaki et al., 1999). Furthermore, results from animal models
suggest that Candida colonization can delay healing of inﬂam-
matory lesions and that inﬂammation promotes colonization as
a positive feedback mechanism. As far as the role of MCs in
the gastrointestinal tract is concerned, a single report suggests
that gastrointestinal Candida colonization promotes sensitiza-
tion against food antigens, at least partly due to MC mediated
hyper permeability of the gastrointestinal mucosa of mice (Yam-
aguchi et al., 2006). Although it is quite probable that MCs
interact with fungi in the intestinal tract and that MCs can play
an important role in host cell defense against gastrointestinal
fungal infections, these issues remain to be clariﬁed by future
research.
POSSIBLE MECHANISMS UNDERLYING MAST CELL
INTERACTION WITH FUNGI
The recognition of fungal pathogens induces innate immune
responses through the engagement of cell surface and/or intra-
cellular PRRs including TLRs and C-type lectin receptors (CLRs;
Heinsbroek et al., 2008). TLRs and CLRs serve as sensitive sensors
against fungal and other pathogens by recognizing pathogen-
associated molecular patterns (PAMPs). Receptor mediated sig-
naling cascades initiated through TLRs or CLRs ultimately pro-
vide an explanation for the kinetics and spectrum of antifungal
innate immune responses (Weis et al., 1998; Kawai and Akira,
2005).
PRESENCE AND IMPLICATIONS OF TLRs AND CLRs ON MAST
CELLS
Mast cells are sentinel cells of the immune system and are found
in greater numbers at sites of pathogen exposure such as the skin
and airways, that is favorable sites for fungi to enter the host. MCs
are bestowed with different types of receptors on their surface that
could be important not only in the recognitionof fungal pathogens
but also in the induction of antifungal responses.
Toll-like receptors, the most widely studied PRRs, are charac-
terized structurally by the presence of a leucine rich repeat (LRR)
domain in their extracellular domain and a Toll/Interleukin-1
receptor (TIR) domain in their intracellular domain. Activa-
tion of TLRs leads to the production of cytokines, chemokines,
and antimicrobial peptides and to the upregulation of stimu-
latory and adhesion molecules in a large array and variety of
cells involved in innate immune responses (Miller and Modlin,
2007). MCs, depending on the subtype and tissue distribution
pattern, differentially express TLRs (Matsushima et al., 2004).
Murine connective tissue typeMCs express TLR3,TLR7,andTLR9
mRNA. In contrast, BMMCs onlymarginally express TLR3, TLR7,
and TLR9 mRNA (Matsushima et al., 2004). Human MCs also
express TLR1 and 6 (McCurdy et al., 2001, 2003), TLR3 (Kulka
et al., 2004), TLR7 (Kulka et al., 2004; Matsushima et al., 2004),
and TLR9 (Zhu and Marshall, 2001) whereas the expression of
TLR5 by MCs remains controversial. Other than TLRs, MCs also
express different type of CLRs that are also crucial for antifungal
responses.
C-type lectin receptors comprise a large family of receptors that
bind to carbohydrates in a calcium-dependent manner. The lectin
activity of these receptors is mediated by conserved carbohydrate-
recognition domains (CRDs). CLRs include Dectin-1, Dectin-2,
macrophage-inducible C-type lectin (Mincle), and the dendritic
cell-speciﬁc ICAM3-grabbing non-integrin (DC-SIGN). CLRs are
involved in fungal recognition and in themodulation of antifungal
innate immune responses. They are expressed by most cell types
including MCs, macrophages, and DCs (Willment and Brown,
2008; Geijtenbeek and Gringhuis, 2009).
Human MCs (Olynych et al., 2006) as well as murine MCs
(Yang and Marshall, 2009) express the Dectin-1 receptor on their
surface. Dectin-1 plays a crucial role in the generation of reac-
tive oxygen species (ROS) through zymosan.MCs can also express
the macrophage-inducible C-type lectin receptorMincle (Ribbing
et al., 2011). TLRs and CLRs play a signiﬁcant role in antifungal
responses of MCs as described below.
ROLE OF TLRs IN RECOGNITION OF FUNGAL COMPONENTS
Toll-like receptors, especially TLR2 and TLR4, have been impli-
cated in the recognition of fungal pathogens such as C. albicans,
A. fumigatus, Cryptococcus neoformans, and Pneumocystis carinii.
Moreover, several PAMPs located in the cell wall or cell surface
of fungi have been identiﬁed as potential TLR-ligands. For exam-
ple, yeast zymosan activates TLR2/TLR6 heterodimers, whereas
C. albicans phospholipomannan is recognized by TLR2 (Jouault
et al., 2003) and glucuronoxylomannan, the major capsular poly-
saccharide of C. neoformans, binds to TLR4 (Shoham et al.,
2001).
Toll-like receptor-4 signals are important for the recognition
of fungal pathogens and their absence may allow for the persis-
tence of infection. TLR4-defective mice, for example, are more
susceptible to C. albicans infection and show reduced chemokine
expression and neutrophil recruitment as compared to wild type
mice (Netea et al., 2002). The absence of functional TLR4 results
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in lower chemotaxis of neutrophils to the site of infection, lower
levels of TNF-α, CXCL1 and nitric oxide, and dissemination and
persistence of the pathogen in lymph nodes and spleen (Gasparoto
et al., 2010). Candida binding to TLR2, along with activation of
dectin-1 (fungal pathogen-recognition receptor), synergistically
induces the production of cytokines such as IL-12 and TNF-α in
macrophages (Gantner et al., 2003). TLR2 is also involved as a
mediator in PGE2 production in response to C. albicans by upreg-
ulating COX-2 expression (Villamon et al., 2005). Infection of
C. albicans in TLR2−/− mice results in reduced Th1 cytokine
production as compared to control mice. On the other hand,
TLR2−/− mice reportedly show normalCandida-speciﬁc humoral
responses and develop normal vaccine-induced resistance (Villa-
mon et al., 2004b). TLR9 is another relevant pathogen-recognition
receptor forC. albicans (Kasperkovitz et al., 2011). TLR9-deﬁcient
(TLR9−/−) mice show a 20–30% reduction in cytokine produc-
tion induced by C. albicans in PBMCs (van de Veerdonk et al.,
2008).
All TLRs, except TLR3, appear to be coupled to the adapter
protein myeloid differentiation primary response gene 88 (MyD88).
TLR-mediated fungal recognition may be through MyD88-
dependent (O’Neill, 2003) or independent pathways (Yamamoto
et al., 2003). For example, the recruitment of neutrophils to the site
of C. albicans infection is signiﬁcantly diminished in MyD88−/−
mice (Villamon et al., 2004a). As of yet, no studies have inves-
tigated the possible role of TLR3 or MyD88 independent path-
ways in the host response to C. albicans infection (Netea et al.,
2008). For Aspergillus, MyD88-deﬁcient mice survived the infec-
tion suggesting a MyD88-independent pathway (Bellocchio et al.,
2004).
Taken together, it appears that MCs are readily equipped with
TLRs and with the necessary downstream signaling intermedi-
ates to translate fungal pathogen detection to protective immune
responses.
ROLE OF C-TYPE LECTIN-LIKE RECEPTORS IN THE
RECOGNITION OF FUNGAL COMPONENTS
Many members of this large receptor family participate in the
recognition of fungal PAMPs in a calcium-dependent fashion
(e.g., dectin-1, dectin-2, Mincle, DC-SIGN/CD209, and mannose
receptor/CD206). Dectin-1 speciﬁcally recognizes soluble or par-
ticulate β-1,3- and/or β-1,6-glucans, which are found in the cell
walls of fungi (Yadav and Schorey, 2006). Dectin-1 is a key recep-
tor involved in mediating the biological effects of β-glucans and
centrally involved in the innate response to fungal pathogens. A
variety of clinically important fungal pathogens are recognized
by dectin-1, e.g., C. albicans and P. carinii. Dectin-1 is expressed
in innate immune cells such as macrophages, neutrophils, DCs,
and MCs. Dectin-1 overexpression results in enhanced binding
of P. carinii to macrophages (Steele et al., 2003), and dectin-1
importantly contributes to the protection against P. carinii by
generating ROS (Saijo and Iwakura, 2011). Dectin-1 expression
in MCs and the induction of dectin-1-dependent ROS produc-
tion are also enhanced by zymosan treatment (Yang and Mar-
shall, 2009). The generation of ROS is known to be essential in
the formation of neutrophil extracellular traps (NETs) to kill
microbes (Brinkmann et al., 2004). NETs can kill both yeast
and hyphal forms of C. albicans (Urban et al., 2006), and since
MCs also have the ability to generate ROS as well as to form
extracellular traps (von Kockritz-Blickwede et al., 2008),MCsmay
Table 1 | Possible mechanism of fungal recognition by mast cells.
Fungal
species
Host
(human/mice)
Cell type Fungal
signal (PAMP)
Receptor or
adaptor protein
Cellular
response
Study
type
Reference
S. cerevisiae Mouse BMMCs Zymosan Dectin-1 Reactive oxygen
species (ROS)
In vitro Yang and Marshall
(2009)
S. cerevisiae Human CBMCs Zymosan Dectin-1 LTB4, LTC4 In vitro Olynych et al.
(2006)
S. cerevisiae Human CBMCs Zymosan TLR2 GM-CSF and IL-1β,
Cys LT
In vitro McCurdy et al.
(2003)
Aspergillus
fumigatus
Rat RBL-2H3 A. fumigatus
hyphae
StuA and MedA
(Regulator)
β-Hexosaminidase In vitro Urb et al. (2009)
Aspergillus
oryzae
Rat RBL-2H3 Aspergillus
oryzae lectin
(AOL)
FcεRI β-Hexosaminidase In vitro Yamaki and
Yoshino (2011)
Malassezia
sympodialis
Mouse BMMCs Malassezia
sympodialis
extract
TLR2/MyD88 IL-6 (Enhancement of
secretion in IgE
receptor cross-linked
BMMCs)
In vitro Selander et al.
(2009)
M. sympodialis Human Peripheral blood MCs M.
sympodialis
extract
Dectin-1 IL-6, IL-8 In vitro Ribbing et al.
(2011)
Abbreviations: BMMCs, bone marrow-derived mast cells; CBMCs, cord blood-derived mast cells; RBL-2H3, rat basophilic leukemia cells.
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contribute to the protection againstC. albicans infection by similar
mechanisms.
Dectin-2 recognizes fungi and induces immune responses
via the activation of the FcRγ chain, which results in the
internalization of fungus compounds and induces secretion of
TNF-α (Sato et al., 2006). Dectin-2 recognizes high mannose
structures of many fungi, including C. albicans, Saccharomyces
cerevisiae, Histoplasma capsulatum, P. brasiliensis, Trichophyton
rubrum (Graham and Brown, 2009), and A. fumigatus (Barrett
et al., 2009). Dectin-2 alongwith FcRγ also plays an important role
in the recognition of house dust mite (Dermatophagoides farina)
and triggers cysteinyl leukotriene generation byMCs (Barrett et al.,
2009). Dectin-2 is also crucial in host defense against C. albicans
by inducing Th17 cell differentiation (Saijo et al., 2010).
All CLRs are coupled to Syk kinase, which allows these recep-
tors to signal via CARD9 leading to NF-κB activation, which in
turn contributes to the induction of both innate and adaptive
immunity against fungal pathogens (Drummond et al., 2011).
CARD9 and Syk regulate different signaling events in which
CARD9 mediates IκBα kinase ubiquitination, whereas Syk reg-
ulates IκBα kinase phosphorylation (Bi et al., 2010). CARD9 is
expressed in MCs albeit at lower levels than in macrophages, DCs,
and neutrophils (Hara et al., 2007). A comprehensive summary of
fungal pathogens, their signal (PAMP) demonstrated to activate
MCs or other cell types in vitro/in vivo, as well as known receptors
or adapter proteins are listed in Tables 1 and 2.
MAST CELL MEDIATOR RELEASE IN RESPONSE TO FUNGAL
INFECTION
MCs release several classes of preformed and de novo synthesized
mediators. PreformedMC products are released by degranulation
and include histamine and proteases. In contrast to bacterial infec-
tions, where MCs appear to contribute to host defense mainly by
the release of preformedmediators (e.g., histamine, proteoglycans,
and proteases), in fungal infections it is the de novo synthesized
mediators that may come out to be protective, although in some
cases preformed mediators may also play an important role. For
example, A. fumigatus hyphae can induce MC degranulation in
the absence of IgE (Urb et al., 2009) while on the other hand A.
fumigatus conidia lack the ability to degranulateMCs. Yamaki and
Yoshino (2011) demonstrated thatAspergillus oryzae lectin (AOL),
a fucose-speciﬁc lectin, induces anaphylactic reactions and MC
activation. AOL induces the release of β-hexosaminidase from the
rat basophilic leukemia cell line RBL-2H3 sensitized with IgE, sug-
gesting the possible implication of AOL in the allergic response to
A. oryzae in humans.
MCs employ many de novo synthesized mediators includ-
ing IL-6, IL-8, IL-1β, IFN-γ, MIP-1α, and MIP-1β. Many of
these mediators have been shown to be involved in protec-
tive host responses to fungal pathogens. For example, IFN-
γ plays a critical role in the control of invasive aspergillo-
sis (Warris et al., 2005). MIP-1α is required for the effer-
ent phase of pulmonary cell-mediated immunity to C. neofor-
mans infection (Huffnagle et al., 1997). Thus, it appears likely
that MC-derived de novo synthesized cytokines and chemokines
can contribute to antifungal innate immune responses. Newly
formed MC lipid mediators may also be involved in fungal
infection. Fungal zymosan can induce leukotriene production
(LTB4 and LTC4) by human MCs through a dectin-1-dependent
mechanism. Yeast zymosan, a potent inducer of GM-CSF
and IL-1β, can also induce substantial short-term cysteinyl
leukotriene generation and can lead to the production of
ROS which may have an important role in the defense
against fungal infection, an area which needs to be explored
more systematically in vivo (Yang and Marshall, 2009). The
role of fungal components in the activation of MCs or
other cell types and their mediator release is summarized in
Tables 1 and 2.
MCs have been reported release of mediators during antifungal
immune responses in vivo, for example againstP. brasiliensis in skin
lesions with loose granuloma and a Th2 pattern of cytokines. MCs
also appear to be a source of IL-10 in paracoccidioidomycosis skin
lesions (Pagliari et al., 2006). Selander et al. (2009) demonstrated
that M. sympodialis extract causes release of cysteinyl leukotrienes
from non-sensitized MCs. It can also enhance MC IgE-dependent
activation, and alters IL-6 production inmouseMCs. In peripheral
bloodMCs from atopic eczema patients, increased amounts of IL-
6 is released after 24 h stimulation with M. sympodialis extract
with or without simultaneous IgE receptor cross-linking (Rib-
bing et al., 2011). These reports further support an important
role for de novo synthesized MC mediators during antifungal host
responses.
CONCLUSION AND OUTLOOK
Our understanding of the role and relevance of MCs in raising
host immune responses to pathogens has improved considerably
over the last 15 years. We now know that MCs are crucial for pro-
tection in many models of bacterial, viral, and parasite infections.
In contrast, we know very little about the role of MCs in fun-
gal infections. This is surprising as there are several independent
lines of evidence that point towards critical effects of MCs in
antifungal host defense responses: MCs are strategically located
to encounter invading fungal pathogens, and they are equipped
with various receptors to detect them and to become activated in
response to them. Also, MCs produce a large array of mediators,
many of which have been shown to contribute to antifungal host
defense.
The ultimate goal of future research should be to translate ﬁnd-
ings from animal models of fungal infection into new treatment
regimes for patients who are vulnerable to lethal fungal infec-
tions. Therefore, in this review, we have presented an overall view
of MCs response to bacterial, viral, and parasitic infections, and
we have given insights into possible defense strategies that could
come into play during fungal infection. We emphasize the need
to characterize the role of MCs in host defense responses against
fungal infections. It is the need of the hour to direct our atten-
tion to the physiological and beneﬁcial functions of MCs and
to re-evaluate them as potentially powerful players in immune
responses against infectious fungi. Thorough research in this
direction may lead to novel and improved therapeutic interven-
tions to combat fungal infections and to reduce their morbidity
and mortality.
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